Safety of Paxlovid Among Patients with Moderate or Severe Hepatic or Renal Impairment

14/12/2022
19/08/2024
EU PAS number:
EUPAS50123
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C4671047_PROTOCOL_V1_16NOV2022

English (3.98 MB - PDF) View document
Updated protocol

C4671047_PROTOCOL AMENDMENT 2_V3_21JUN2023_SIGNED

First published: 22/02/2024
English (1.32 MB - PDF) View document
Study results
Study report
Other information
Study, other information

1047_DeclarationofInterests_combined.pdf

English (2.79 MB - PDF) View document

1047_DeclarationofInterests-Annex5_template _Muhammad Younus.pdf

English (104.35 KB - PDF) View document